Leap therapeutics inc Results

You are searching for Leap therapeutics inc, Below listing suggest some keywords related this keyword and listing websites with same content

Find Top Domain Names With

Searches related

Top Keywords Suggestions

1 Leap therapeutics inc
2 Leap therapeutics inc. lptx
3 Leap therapeutics inc stock
4 Leap therapeutics inc stock price

Most Searched Keywords

Domains Actived Recently

   » Dv-us.com (6 seconds ago)

   » Hoegl.com (5 seconds ago)

   » Cashforcarsdallas.org (0 seconds ago)

   » Chiriqui.org (7 seconds ago)

   » Benhogangolf.com (2 seconds ago)

   » Sprintrelay.com (2 seconds ago)

   » Merrimackvet.com (5 seconds ago)

   » Ircgroupglobal.com (7 seconds ago)

   » Mddus.com (7 seconds ago)

   » Neiksansrallysport.com (5 seconds ago)

Extract All Emails from Any Domain

Find All Domains on Any IP/ Domain

About 46 Websites Link


Leap Therapeutics, Inc. (LPTX) Stock Price, News, Quote

Finance.yahoo.com   DA: 17 PA: 12 MOZ Rank: 29

  • (LPTX) is technically in oversold territory now, so the heavy selling pressure might have exhausted
  • This along with strong agreement among Wall Street analysts in raising

LPTX Stock Price Leap Therapeutics Inc. Stock Quote (U.S

Marketwatch.com   DA: 19 PA: 21 MOZ Rank: 41

  • is a clinical stage biopharmaceutical company, which engages in developing novel therapies designed to treat patients with cancer
  • Its clinical stage programs are DKN-01

Leap Therapeutics, Inc. (LPTX) Company Profile & Facts

Finance.yahoo.com   DA: 17 PA: 20 MOZ Rank: 39

  • Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer
  • Its lead clinical stage programs include DKN-01, a monoclonal antibody that

Leap Therapeutics LinkedIn

Linkedin.com   DA: 16 PA: 26 MOZ Rank: 45

  • Leap Therapeutics | 1,084 followers on LinkedIn
  • Leap Therapeutics (NASDAQ: LPTX) is a clinical-stage biopharmaceutical company acquiring and developing novel therapeutics at the leading edge of

Management Page Leap Therapeutics

Leaptx.com   DA: 14 PA: 16 MOZ Rank: 34

  • Doug Onsi has served as Leap’s Chief Financial Officer, Treasurer and Secretary since 2011 and became the President & CEO in April of 2020
  • He has been at HealthCare Ventures since 2007, including serving as a managing director since 2009 and the chief executive officer of Tensha Therapeutics, Inc
  • which was sold to Roche Holdings, Inc.

Down 19.5% In 4 Weeks, Here's Why You Should You Buy The

Nasdaq.com   DA: 14 PA: 50 MOZ Rank: 69

  • (LPTX) has been beaten down lately with too much selling pressure
  • While the stock has lost 19.5% over the past four weeks, there is …

Leap Therapeutics To Present At Ladenburg Thalmann 2021

Investors.leaptx.com   DA: 20 PA: 50 MOZ Rank: 76

  • CAMBRIDGE, Mass., July 7, 2021 /PRNewswire/ -- Leap Therapeutics, Inc
  • (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that Douglas E
  • Onsi, President and Chief Executive Officer, will present a corporate overview at the Ladenburg Thalmann 2021 Virtual Healthcare Conference on …

Leap Therapeutics Inc (LPTX) Quote

Morningstar.com   DA: 19 PA: 23 MOZ Rank: 49

Leap Therapeutics Inc is a biopharmaceutical company developing novel therapies designed to treat patients with cancer by inhibiting fundamental tumor-promoting pathways and by harnessing the

Leap Therapeutics Reports First Quarter 2021 Financial

Investors.leaptx.com   DA: 20 PA: 50 MOZ Rank: 78

  • CAMBRIDGE, Mass., May 14, 2021 /PRNewswire/ -- Leap Therapeutics, Inc
  • (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today reported financial results for the first quarter ended March 31, 2021
  • Leap First Quarter Highlights: Completed enrollment for first-line patient cohort in the DisTinGuish study, a clinical trial evaluating Leap

Leap Therapeutics Inc (LPTX : NASDAQ) Stock Price & News

Google.com   DA: 14 PA: 26 MOZ Rank: 49

Get the latest Leap Therapeutics Inc (LPTX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

Leap Therapeutics And BeiGene Announce Exclusive Option

Investors.leaptx.com   DA: 20 PA: 50 MOZ Rank: 80

News Releases Leap Therapeutics, Inc.

Investors.leaptx.com   DA: 20 PA: 27 MOZ Rank: 58

  • Leap Therapeutics to Present at Ladenburg Thalmann 2021 Virtual Healthcare Conference
  • Leap Therapeutics to Present at Raymond James 2021 Virtual Human Health Innovation Conference
  • Leap Therapeutics Reports First Quarter 2021 Financial Results

LPTX Stock Forecast, Price & News (Leap Therapeutics)

Marketbeat.com   DA: 18 PA: 20 MOZ Rank: 50

  • Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer
  • Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1 that is in multiple clinical trials for treating esophagogastric cancer, hepatobiliary cancer, gynecologic cancers, and prostate cancer.

LPTX Leap Therapeutics Inc. Profile MarketWatch

Marketwatch.com   DA: 19 PA: 37 MOZ Rank: 69

  • is a clinical stage biopharmaceutical company, which engages in developing novel therapies designed to treat patients with cancer
  • Its clinical stage programs are DKN-01

Leap Therapeutics, Inc.

Zacks.com   DA: 13 PA: 21 MOZ Rank: 48

  • It develops novel therapeutics for the treatment of cancer
  • is based in Cambridge, United States.

LEAP THERAPEUTICS, INC. : Submission Of Matters To A Vote

Marketscreener.com   DA: 22 PA: 50 MOZ Rank: 87

  • Item 5.07 Submission of Matters to a Vote of Security Holders
  • held its 2021 Annual Meeting of Stockholders on June 15, …

LPTX Leap Therapeutics Inc. Stock Price & News

Wsj.com   DA: 11 PA: 24 MOZ Rank: 51

  • News Leap Therapeutics Inc.LPTX
  • The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per

Leap Therapeutics, Inc. (LPTX) Latest Stock News

Finance.yahoo.com   DA: 17 PA: 17 MOZ Rank: 51

  • (LPTX) delivered earnings and revenue surprises of -9.09% and -3.85%, respectively, for the quarter ended March 2021
  • Do the numbers hold clues to what lies ahead for the

LPTX:NASDAQ GM Stock Quote

Bloomberg.com   DA: 17 PA: 14 MOZ Rank: 49

  • operates as a clinical-stage biopharmaceutical company
  • The Company develops novel therapeutics for the treatment of cancer

Leap Therapeutics Inc

Reuters.com   DA: 15 PA: 34 MOZ Rank: 68

  • Leap Therapeutics Reports Qtrly Loss Per Share Of $0.12
  • May 14 (Reuters) - Leap Therapeutics Inc <LPTX.O>::LEAP THERAPEUTICS INC - CASH AND CASH EQUIVALENTS TOTALED $43.5 MILLION AT MARCH 31, 2021.

Leap Therapeutics Inc. (NASDAQ: LPTX): A Great Stock To

Stocksregister.com   DA: 18 PA: 50 MOZ Rank: 88

  • Nearly 12.61% of Leap Therapeutics Inc.’s shares belong to company insiders and institutional investors own 39.00% of the company’s shares
  • The data on short interest also indicates that stock shorts accounted for 1.18 million shares as on May 13, 2021, resulting in a short ratio of 2.8.

Leap Therapeutics, Inc. DEF 14A Apr. 29, 2020 10:17 AM

Seekingalpha.com   DA: 16 PA: 15 MOZ Rank: 52

  • 47 Thorndike Street, Suite B1-1 Cambridge, MA 02141
  • PROXY STATEMENT FOR 2020 ANNUAL MEETING OF STOCKHOLDERS

Leap Therapeutics Inc (LPTX) Stock Price History Wallmine

Wallmine.com   DA: 12 PA: 12 MOZ Rank: 46

  • Leap Therapeutics Inc www.leaptx.com
  • Leap Therapeutics is focused on developing targeted and immuno-oncology therapeutics
  • Leap's most advanced clinical candidate, DKN-01, is a humanized monoclonal antibody targeting the Dickkopf-1 (DKK1) protein, a Wnt pathway modulator
  • DKN-01 is in clinical trials in patients with esophagogastric

What You Need To Know About Leap Therapeutics, Inc.'s

Finance.yahoo.com   DA: 17 PA: 50 MOZ Rank: 90

  • If you want to know who really controls Leap Therapeutics, Inc
  • (NASDAQ:LPTX), then you'll have to look at the makeup of its share registry.Insiders often own a large chunk of younger, smaller

Leap Therapeutics, Inc. (LPTX) Reports Q1 Loss, Lags

Nasdaq.com   DA: 14 PA: 50 MOZ Rank: 88

  • (LPTX) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of a loss of $0.11

Down 19.5% In 4 Weeks, Here's Why You Should You Buy The

Zacks.com   DA: 13 PA: 50 MOZ Rank: 88

  • (LPTX Quick Quote LPTX - Free Report) has been beaten down lately with too much selling pressure.While the stock has lost …

LPTX Leap Therapeutics Inc. Company Profile & Executives

Wsj.com   DA: 11 PA: 39 MOZ Rank: 76

  • is a clinical stage biopharmaceutical company, which engages in developing novel therapies designed to treat patients with cancer
  • Its clinical stage programs are DKN-01

Leap Therapeutics Inc. Stock Price (LPTX) Barron's

Barrons.com   DA: 15 PA: 25 MOZ Rank: 67

  • View today's stock price, news and analysis for Leap Therapeutics Inc
  • Barron's also provides information on historical stock ratings, target …

Leap Therapeutics, Inc. (LPTX) Reports Q1 Loss, Lags

Zacks.com   DA: 13 PA: 50 MOZ Rank: 91

  • (LPTX) delivered earnings and revenue surprises of -9.09% and -3.85%, respectively, for the quarter ended March 2021

LEAP THERAPEUTICS, INC. (Form: 8-K, Received: 01/26/2017

Content.edgar-online.com   DA: 24 PA: 45 MOZ Rank: 98

  • (originally incorporated under the name Dekkun Corporation), a corporation hereby organized and existing under the laws of the State of Delaware (the “ Corporation ”), does hereby certify: 1
  • The name of the Corporation is “Leap Therapeutics, Inc.” The date of filing the original Certificate of Incorporation of

Leap Therapeutics, Inc. (LPTX) Reports Q1 Loss, Lags

Finance.yahoo.com   DA: 17 PA: 50 MOZ Rank: 97

  • (LPTX) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of a loss of $0.11
  • This compares to loss of $0.55 per share a year ago.

LEAP THERAPEUTICS, INC. (Form: 8-K, Received: 01/03/2020

Content.edgar-online.com   DA: 24 PA: 45 MOZ Rank: 100

  • On January 3, 2020, Leap Therapeutics, Inc
  • (the “Company”) entered into an exclusive option and license agreement (the “License Agreement”) with BeiGene, Ltd
  • (“BeiGene”) for the clinical development and commercialization of DKN-01, the Company’s anti-Dickkopf-1 (DKK1) antibody, in Asia (excluding Japan), Australia, and New Zealand.

LPTX Leap Therapeutics, Inc. Stock Quote

Finviz.com   DA: 10 PA: 11 MOZ Rank: 53

  • Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer
  • Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1 that is in multiple clinical trials for treating esophagogastric cancer, hepatobiliary cancer, gynecologic cancers, and prostate cancer.

LEAP THERAPEUTICS, INC. (Form: 8-K, Received: 09/10/2020

Content.edgar-online.com   DA: 24 PA: 45 MOZ Rank: 17

  • (Pursuant to Section 151(g) of the General Corporation Law of the State of Delaware) _____ Leap Therapeutics, Inc., a corporation organized and existing under the laws of the State of Delaware (the “Corporation”), in accordance with the provisions of

LPTX Company Profile & Executives

Wsj.com   DA: 11 PA: 50 MOZ Rank: 95

  • Independent Director, Leap Therapeutics, Inc
  • Nissim Mashiach founded Nubiyota LLC
  • Mashiach is on the board of MediWound Ltd

LEAP THERAPEUTICS, INC. (Form: 8-K, Received: 06/25/2020

Content.edgar-online.com   DA: 24 PA: 45 MOZ Rank: 15

  • Exhibit 99.1 Leap Therapeutics Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares
  • Cambridge, MA – June 25, 2020 – Leap Therapeutics, Inc
  • (NASDAQ:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced the closing of an additional 3,375,000 shares of common stock …

Athos Therapeutics, Inc. In Los Angeles, CA Company Info

Bizapedia.com   DA: 17 PA: 31 MOZ Rank: 84

  • is a California Foreign Corporation filed On April 17, 2019
  • The company's filing status is listed as Active and its File Number is C4264687
  • The Registered Agent on file for this company is Dimitrios Iliopoulos and is located at 11301 Olympic Blvd Apt 592, Los Angeles, CA 90064.

Leap Therapeutics, Inc. 2021 Security Sale/Purchase Record

Sec.report   DA: 10 PA: 31 MOZ Rank: 78

  • Statement of changes in beneficial ownership of securities
  • Form 4 (Reporting) Published: 2021-05 …

LEAP THERAPEUTICS, INC. (Form: 8-K, Received: 11/17/2017

Content.edgar-online.com   DA: 24 PA: 45 MOZ Rank: 12

Leap Therapeutics, Inc., a Delaware corporation (the “ Company ”), certifies that, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, [ ], the registered holder hereof or its permitted assigns (the “ Holder ”), is entitled, subject to the terms and conditions set forth below, to purchase

Should I Buy Leap Therapeutics, Inc. (LPTX)

Zacks.com   DA: 13 PA: 39 MOZ Rank: 91

  • (LPTX) Reports Q4 Loss, Lags Revenue Estimates 03/12/21-7:15AM EST Zacks Company News for Jun 15, 2020 06/15/20-8:58AM EST Zacks

Employment Agreement, Employment Agreement Template

Agreements.realdealdocs.com   DA: 27 PA: 30 MOZ Rank: 97

  • Employment Agreement - Copy, edit and use these Sample Employment Agreements and Contracts
  • Actual legal documents drafted by top law firms for their clients
  • Use them as Employment Agreement samples, Employment Agreement templates, competitive intelligence, drafting documents or to get information about transactions within a particular industry or sector.

Leap Therapeutics Announces Publication Of DKN-01

Prnewswire.com   DA: 18 PA: 50 MOZ Rank: 9

  • Leap Therapeutics (Nasdaq:LPTX) is focused on developing targeted and immuno-oncology therapeutics
  • Leap's most advanced clinical candidate, DKN-01, is a humanized monoclonal antibody targeting

Recently Analyzed Sites

Dv-us.com (6 seconds ago)

Hoegl.com (5 seconds ago)

Cashforcarsdallas.org (0 seconds ago)

Chiriqui.org (7 seconds ago)

Benhogangolf.com (2 seconds ago)

Sprintrelay.com (2 seconds ago)

Merrimackvet.com (5 seconds ago)

Ircgroupglobal.com (7 seconds ago)

Mddus.com (7 seconds ago)

Neiksansrallysport.com (5 seconds ago)

Transports-gagne.com (7 seconds ago)

Osgcanada.com (3 seconds ago)

Sceco2030.com (4 seconds ago)

Roscoeapts.com (8 seconds ago)

Dailyhyundaidongdo.com (3 seconds ago)

Riflescope-review.com (17 seconds ago)

Paapaii.com (12 seconds ago)

Erinhyattphotography.com (0 seconds ago)